Ecole Polytechnique Federale de Lausanne, TES Pharma deal

TES and Ecole Polytechnique Federale de Lausanne (EPFL) partnered to develop small molecule modulators of the kynurenine pathway to treat metabolic disorders and age-related diseases. The companies c...